BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38112846)

  • 1. C-reactive protein levels, the prognostic nutritional index, and the lactate dehydrogenase-to-lymphocyte ratio are important prognostic factors in primary central nervous system lymphoma: a single-center study of 223 patients.
    Zuo J; Lei T; Zhong S; Zhou J; Liu R; Wu C; Li S
    Neurosurg Rev; 2023 Dec; 47(1):17. PubMed ID: 38112846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Prognostic Marker for Primary CNS Lymphoma: Lactate Dehydrogenase-to-Lymphocyte Ratio Improves Stratification of Patients Within the Low and Intermediate MSKCC Risk Groups.
    Gao Y; Wei L; Kim SJ; Wang L; He Y; Zheng Y; Bertero L; Pellerino A; Cassoni P; Tamagnone L; Theresa PK; Deutsch A; Zhan H; Lai J; Wang Y; You H
    Front Oncol; 2021; 11():696147. PubMed ID: 34422649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel prognostic model based on pretreatment serum albumin and ECOG PS for primary CNS lymphoma: an international, multi-center study.
    Wei L; Gao Y; Prochazka KT; Liu R; Wang L; Liu B; He Y; Bertero L; Pellerino A; Cassoni P; Tamagnone L; Deutsch AJ; Zhan H; Lai J; Kim SJ; You H
    J Neurooncol; 2023 Jun; 163(2):301-311. PubMed ID: 37231231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Letter to editor: C‑reactive protein levels, the prognostic nutritional index, and the lactate dehydrogenase‑to‑lymphocyte ratio are important prognostic factors in primary central nervous system lymphoma: a single‑center study of 223 patients.
    Un Nisa Mughal Z; Haseeb A
    Neurosurg Rev; 2024 Apr; 47(1):146. PubMed ID: 38600419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretreatment Hemoglobin as an Independent Prognostic Factor in Primary Central Nervous System Lymphomas.
    Le M; Garcilazo Y; Ibáñez-Juliá MJ; Younan N; Royer-Perron L; Benazra M; Mokhtari K; Houillier C; Hoang-Xuan K; Alentorn A
    Oncologist; 2019 Sep; 24(9):e898-e904. PubMed ID: 30867243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Memorial Sloan-Kettering Cancer Center and International Extranodal Lymphoma Study Group prognostic scoring systems to predict Overall Survival in intracranial Primary CNS lymphoma.
    Jahr G; Broi MD; Holte H; Beiske K; Meling TR
    Brain Behav; 2018 Mar; 8(3):e00928. PubMed ID: 29541540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new prognostic score for disease progression and mortality in patients with newly diagnosed primary CNS lymphoma.
    Liu CJ; Lin SY; Yang CF; Yeh CM; Kuan AS; Wang HY; Tsai CK; Gau JP; Hsiao LT; Chen PM; Liu YC; Hong YC; Ko PS; Liu JH; Lin CH
    Cancer Med; 2020 Mar; 9(6):2134-2145. PubMed ID: 32011103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proposed new prognostic model using the systemic immune-inflammation index for primary central nervous system lymphoma: A prospective-retrospective multicohort analysis.
    Li S; Xia Z; Cao J; Zhang J; Chen B; Chen T; Zhang X; Zhu W; Li D; Hua W; Mao Y
    Front Immunol; 2022; 13():1039862. PubMed ID: 36439151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined tumor-associated macrophages biomarker predicting extremely poor outcome of patients with primary central nervous system lymphoma.
    Sun X; Wang C; Chen C; Huang J; Wu X; Wang Y; He X; Cao J; Jiang W; Sun P; Li Z
    Hematol Oncol; 2021 Dec; 39(5):625-638. PubMed ID: 34543472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relevance of different prognostic scores in primary CNS lymphoma in the era of intensified treatment regimens: A retrospective, multicenter analysis of 174 patients.
    Zeremski V; Adolph L; Beer S; Berisha M; Jacobs B; Kahl C; Koenecke C; Kropf S; Panse J; Petersen J; Schmidt-Hieber M; Schneider J; Vucinic V; Walter J; Weigert O; Witte HM; Mougiakakos D
    Eur J Haematol; 2024 Apr; 112(4):641-649. PubMed ID: 38164819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of POD18 combined with improved IELSG in primary central nervous system lymphoma.
    Du KX; Shen HR; Pan BH; Luthuli S; Wang L; Liang JH; Li Y; Yin H; Li JY; Wu JZ; Xu W
    Clin Transl Oncol; 2024 Mar; 26(3):720-731. PubMed ID: 37558851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of comorbidity indices and histochemical markers in surgically resected and non-resected primary central nervous system lymphoma.
    Wong CE; Liao WA; Chang Y; Lee PH; Huang CC; Chang KC; Lee JS
    Clin Exp Med; 2023 Nov; 23(7):3799-3807. PubMed ID: 37491648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological analysis and specific discriminating markers of interleukin detection in cerebrospinal fluid with primary central nervous system lymphoma: results from a retrospective study.
    Li J; Tang X; Luo X; Liu L; Li D; Yang L
    Ann Hematol; 2023 Aug; 102(8):2153-2163. PubMed ID: 37289220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Role of Blood Markers in Primary Central Nervous System Lymphoma Patients Treated With High-Dose Methotrexate-Based Therapy.
    Luo Q; Yang C; Fu C; Wu W; Wei Y; Zou L
    Front Oncol; 2021; 11():639644. PubMed ID: 33996552
    [No Abstract]   [Full Text] [Related]  

  • 15. Complete Blood Count Score Model Predicts Inferior Prognosis in Primary Central Nervous System Lymphoma.
    Feng Y; Liu Y; Zhong M; Wang L
    Front Oncol; 2021; 11():618694. PubMed ID: 33842320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Easier and more explanatory indices by integrating leukocyte lymphocyte ratio (LLR) and prognostic nutritional index (PNI) to IPS systems in cases with classical Hodgkin lymphoma.
    Paydas S; Lacin S; Dogan M; Barista I; Yildiz B; Seydaoglu G; Karadurmus N; Civriz S; Kaplan MA; Yagci M; Dincyurek HD; Ercolak V
    Leuk Res; 2021 Aug; 107():106586. PubMed ID: 34082249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of prognostic nutritional index in nasal-type, extranodal natural killer/T-cell lymphoma.
    Li N; Jiang M; Wu WC; Zou LQ
    Ann Hematol; 2022 Jul; 101(7):1545-1556. PubMed ID: 35635579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic nutritional index, a novel biomarker which predicts worse prognosis in diffuse large B cell lymphoma.
    He J; Yin H; Xia Y; Wu JZ; Liang JH; Zhu HY; Fan L; Li JY; Wang L; Xu W
    Leuk Res; 2021 Nov; 110():106664. PubMed ID: 34271293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Characteristics, Surgical Outcomes, and Prognostic Factors of Intracranial Primary Central Nervous System Lymphoma.
    Ouyang T; Wang L; Zhang N; Zhang Z; Xiong Y; Li M; Hong T
    World Neurosurg; 2020 Jul; 139():e508-e516. PubMed ID: 32311566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic value of prognostic nutritional index (PNI) and neutrophil to lymphocyte ratio (NLR) for advanced non-small cell lung cancer treated with platinum-based chemotherapeutics.
    Wang J; Liu Y; Mi X; Shao M; Liu L
    Ann Palliat Med; 2020 May; 9(3):967-978. PubMed ID: 32389020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.